Astera Labs (NASDAQ:ALAB) Shares Up 6.7% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares rose 6.7% during mid-day trading on Tuesday . The company traded as high as $369.15 and last traded at $363.46. Approximately 5,392,056 shares traded hands during trading, an increase of 2% from the average session volume of 5,269,410 shares. The stock had previously closed at $340.74.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ALAB. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price for the company in a research note on Monday, August 17th. Bank of America boosted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Susquehanna upped their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, TD Cowen dropped their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Performance

The firm has a market capitalization of $63.06 billion, a P/E ratio of 179.93 and a beta of 3.77. The stock has a fifty day moving average price of $302.90 and a two-hundred day moving average price of $268.04.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director directly owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 592,244 shares of company stock worth $209,729,973. Company insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP raised its stake in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares in the last quarter. Van ECK Associates Corp raised its position in Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after acquiring an additional 373,545 shares in the last quarter. Finally, Bank of America Corp DE bought a new stake in Astera Labs during the second quarter worth approximately $1,061,791,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.